Culture-guided management of local infection, cellulitis, biofilm, and osteomyelitis.
An infected wound is one in which microorganisms have invaded viable tissue and multiplied to a level that provokes a host immune response and impairs healing. Infection exists along a continuum: contamination and colonization (organisms present without harm), local infection (bacterial burden causing delayed healing and subtle local signs), spreading infection or cellulitis (erythema, warmth, and swelling extending beyond the wound margin), and systemic infection or sepsis. Many chronic wounds also harbor biofilm — structured communities of bacteria encased in a protective matrix that resists antibiotics and host defenses. Deep infection can extend to underlying bone, producing osteomyelitis.
Also known as: Wound infection, Infected ulcer, Wound cellulitis, Critical colonization, Biofilm-laden wound.
Common signs and symptoms can vary by wound type and severity.
A clinician evaluates the wound together with the factors that may delay healing.
Seek urgent evaluation for spreading redness, red streaking, fever, rapidly worsening pain, or purulent drainage, and call 911 for signs of sepsis such as confusion, very rapid heart rate, or difficulty breathing. Early antibiotic and wound treatment prevents progression to cellulitis, osteomyelitis, or life-threatening systemic infection.
Healix360 supports access to advanced mobile wound care services for patients throughout our coverage area. Services are delivered by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds, including infected wounds. Care is coordinated and provided directly to patients in private residences, assisted living communities, and skilled nursing facilities.
Our clinicians assess each wound against the wound infection continuum, distinguishing local infection from spreading cellulitis and screening for deep involvement such as osteomyelitis. We obtain wound cultures to guide targeted, culture-directed antibiotic therapy rather than relying on broad-spectrum guesswork. Central to our approach is disruption of biofilm through sharp debridement, antimicrobial cleansing, and topical antimicrobial dressings, combined with exudate management and, when appropriate, systemic antibiotics coordinated with the patient's physician.
With culture-guided antibiotic therapy, thorough debridement, biofilm disruption, and antimicrobial wound management, most localized wound infections resolve and healing resumes. Early, coordinated treatment substantially lowers the risk of progression to cellulitis, osteomyelitis, amputation, or sepsis.
Warning signs include increasing pain, redness, warmth, and swelling; pus or foul-smelling drainage; a wound that stops healing or worsens; and red streaking, fever, or feeling generally unwell. Any of these warrants prompt professional evaluation.
A local infection is confined to the wound and its immediate edges, whereas cellulitis is a spreading infection of the surrounding skin and soft tissue that produces expanding redness, warmth, and swelling beyond the wound margin. Cellulitis usually requires systemic antibiotics.
Biofilm is a protective community of bacteria bonded to the wound surface by a slimy matrix that shields them from antibiotics and the immune system. It is a major cause of chronic, non-healing wounds and is best managed with repeated debridement combined with antimicrobial dressings.
A culture identifies the specific organisms present and their antibiotic sensitivities, allowing clinicians to select targeted therapy instead of broad-spectrum antibiotics. Culture-guided treatment improves outcomes and helps reduce antibiotic resistance.
Yes. Many wound infections are managed effectively at home with in-person clinician visits for debridement, culture-guided antibiotics, and antimicrobial dressings. Deep infections such as osteomyelitis or signs of sepsis require hospital-level care, which we help coordinate. These medically necessary services are typically covered under Medicare Part B.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.